methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

C59H58N8O6 — CID 126684950

IUPACmethyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
SMILESCOC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc(-c3cc4ccc3CCc3ccc(c(-c5ccc6nc([C@@H]7CCCN7C(=O)[C@@H](NC(=O)OC)c7ccccc7)[nH]c6c5)c3)C[C@H]4C)cc2[nH]1)c1ccccc1
InChIInChI=1S/C59H58N8O6/c1-35-30-41-21-19-36(31-44(41)42-24-26-46-48(33-42)62-54(60-46)50-16-10-28-66(50)56(68)52(64-58(70)72-2)38-12-6-4-7-13-38)18-20-37-22-23-40(35)32-45(37)43-25-27-47-49(34-43)63-55(61-47)51-17-11-29-67(51)57(69)53(65-59(71)73-3)39-14-8-5-9-15-39/h4-9,12-15,19,21-27,31-35,50-53H,10-11,16-18,20,28-30H2,1-3H3,(H,60,62)(H,61,63)(H,64,70)(H,65,71)/t35-,50+,51+,52+,53+/m1/s1
InChIKeyIDWUXKDNSPFJDN-NZZQPSRCSA-N
MW975.16 g/mol
LogP10.74
Rot. Bonds10

About methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate

methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (PubChem CID 126684950) has the molecular formula C59H58N8O6 and a molecular weight of 975.16 g/mol. Its IUPAC name is methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate.

Molecular Properties

Compound Namemethyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
PubChem CID126684950
Molecular FormulaC59H58N8O6
Molecular Weight975.16 g/mol
Exact Mass974.45
IUPAC Namemethyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate
SMILESCOC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc(-c3cc4ccc3CCc3ccc(c(-c5ccc6nc([C@@H]7CCCN7C(=O)[C@@H](NC(=O)OC)c7ccccc7)[nH]c6c5)c3)C[C@H]4C)cc2[nH]1)c1ccccc1
InChIInChI=1S/C59H58N8O6/c1-35-30-41-21-19-36(31-44(41)42-24-26-46-48(33-42)62-54(60-46)50-16-10-28-66(50)56(68)52(64-58(70)72-2)38-12-6-4-7-13-38)18-20-37-22-23-40(35)32-45(37)43-25-27-47-49(34-43)63-55(61-47)51-17-11-29-67(51)57(69)53(65-59(71)73-3)39-14-8-5-9-15-39/h4-9,12-15,19,21-27,31-35,50-53H,10-11,16-18,20,28-30H2,1-3H3,(H,60,62)(H,61,63)(H,64,70)(H,65,71)/t35-,50+,51+,52+,53+/m1/s1
InChIKeyIDWUXKDNSPFJDN-NZZQPSRCSA-N
XLogP10.74
TPSA174.64 Ų
H-Bond Donors4
H-Bond Acceptors8
Rotatable Bonds10
Heavy Atoms73
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500975.16
LogP ≤ 510.74
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 108

Analyze methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate?
The IUPAC name of methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate (CID 126684950) is methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate.
What is the SMILES notation for methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate?
The canonical SMILES for methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate is COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc2ccc(-c3cc4ccc3CCc3ccc(c(-c5ccc6nc([C@@H]7CCCN7C(=O)[C@@H](NC(=O)OC)c7ccccc7)[nH]c6c5)c3)C[C@H]4C)cc2[nH]1)c1ccccc1.
What is the InChIKey of methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate?
The InChIKey is IDWUXKDNSPFJDN-NZZQPSRCSA-N. The full InChI is InChI=1S/C59H58N8O6/c1-35-30-41-21-19-36(31-44(41)42-24-26-46-48(33-42)62-54(60-46)50-16-10-28-66(50)56(68)52(64-58(70)72-2)38-12-6-4-7-13-38)18-20-37-22-23-40(35)32-45(37)43-25-27-47-49(34-43)63-55(61-47)51-17-11-29-67(51)57(69)53(65-59(71)73-3)39-14-8-5-9-15-39/h4-9,12-15,19,21-27,31-35,50-53H,10-11,16-18,20,28-30H2,1-3H3,(H,60,62)(H,61,63)(H,64,70)(H,65,71)/t35-,50+,51+,52+,53+/m1/s1.
What are the key properties of methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate?
methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate has a molecular weight of 975.16 g/mol, XLogP of 10.74, 10 rotatable bonds, 4 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for methyl N-[(1S)-2-[(2S)-2-[6-[(2R)-11-[2-[(2S)-1-[(2S)-2-(methoxycarbonylamino)-2-phenylacetyl]pyrrolidin-2-yl]-3H-benzimidazol-5-yl]-2-methyl-5-tricyclo[8.2.2.24,7]hexadeca-1(12),4,6,10,13,15-hexaenyl]-1H-benzimidazol-2-yl]pyrrolidin-1-yl]-2-oxo-1-phenylethyl]carbamate is sourced from PubChem (CID 126684950), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).